Ribatti, D., Solimando, A. G., & Pezzella, F. (2021). The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers (Basel).
Citación estilo ChicagoRibatti, Domenico, Antonio Giovanni Solimando, and Francesco Pezzella. "The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates By Breaking the Vicious Cycle of Angiogenesis in Cancer." Cancers (Basel) 2021.
Cita MLARibatti, Domenico, Antonio Giovanni Solimando, and Francesco Pezzella. "The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates By Breaking the Vicious Cycle of Angiogenesis in Cancer." Cancers (Basel) 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.